Image

The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes

The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes

Recruiting
35-75 years
All
Phase N/A

Powered by AI

Overview

The primary aim of this randomized cross-over intervention study is to investigate the effect of four weeks of intermittent carbohydrate restriction (alternating between two days of normal dietary intake and two days of carbohydrate restriction to 70-90 grams) on 24-hour average sensor glucose in individuals with type 2 diabetes compared with a four-week control period with normal dietary intake.

Eligibility

Inclusion Criteria:

  • Men or women
  • 35-75 years old
  • BMI >27 kg/m2
  • Known type 2 diabetes in stable glucose lowering therapy (for three months) or with HbA1c >48 mmol/mol if no glucose lowering therapy

Exclusion Criteria:

  • Anemia (hemoglobin <8 mmol/L for men and <7 mmol/L for women)
  • TSH outside reference range
  • Treatment with insulin, sulfonylurea, or SGLT2-inhibitors
  • Treatment with systemic corticosteroids
  • HbA1c >70 mmol/mol
  • eGFR <60 ml/min/1.73 m2
  • Contraindications for MR-scan: abdominal height exceed limitations of the MR-scanner, pacemaker or other electronic device implanted, implanted metal devices, severe claustrophobia
  • Food allergies (including lactose and gluten intolerance)
  • Vegetarian/vegan diet or following of specific dietary plans
  • Alcohol consumptions >84/168 g/week (women/men)
  • Strenuous activity level > 120 minutes per week
  • Weight loss (>5 kg) within the last three months or previous bariatric surgery
  • High risk of fibrosis of the liver (estimated by FIB4 score > 3.25)

Study details
    Diabetes Mellitus
    Type 2
    Overweight and Obesity
    Non-Alcoholic Fatty Liver Disease
    Metabolic Syndrome

NCT06144593

Hvidovre University Hospital

16 June 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.